RUNX1 and myelodysplastic syndrome: In addition, three high-risk MDS patients (5%) displayed chromothripsis involving chromosomes 6p, 12, 16p, 18q, 19p, and 21q and affecting the ETV6, U2AF1, and RUNX1 genes, among others.